Avidity Biosciences (NASDAQ:RNA) Stock Price Expected to Rise, Citigroup Analyst Says
Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its price target raised by Citigroup from $70.00 to $75.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Citigroup’s price target would suggest a potential upside of 134.30% from the company’s current price. Other equities […]
Avidity Biosciences (NASDAQ:RNA – Get Free Report) had its price target raised by Citigroup from $70.00 to $75.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Citigroup’s price target would suggest a potential upside of 134.30% from the company’s current price. Other equities […]
